Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: drug efficacy assessment

Phase IV Clinical Trials: Post-Marketing Surveillance and Long-Term Safety Monitoring

Posted on May 9, 2025 digi By digi

Phase IV Clinical Trials: Post-Marketing Surveillance and Long-Term Safety Monitoring Comprehensive Guide to Phase IV Clinical Trials: Post-Marketing Surveillance and Real-World Evidence Generation Phase IV clinical trials, also known as post-marketing surveillance studies, extend the evaluation of new drugs beyond regulatory approval. By monitoring real-world use, identifying rare adverse events, and assessing long-term safety and…

Read More “Phase IV Clinical Trials: Post-Marketing Surveillance and Long-Term Safety Monitoring” »

Clinical Trial Phases, Phase 4 (Post-Marketing Surveillance)

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
  • Clinical Trial Design and Protocol Development
  • Good Clinical Practice (GCP) and Compliance
  • U.S. FDA Regulations

Menu

Recent Posts

  • Role of Phase 3 Trials in Accelerated Approvals and Fast Track Designations: Regulatory Pathways and Clinical Implications
  • Immunotherapy Phase 2 Trial Considerations
  • Emerging Tools for Phase 4 Signal Detection: Advancing Post-Marketing Safety Monitoring
  • The Role of Pharmacometrics in Dose Prediction for Phase 1
  • Case Studies of Successful Phase 3 Drug Approvals: Lessons in Design, Strategy, and Execution

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme